Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of CareSusan Olender, Bindu Balani, Eboni G. Price‐Haywood et al.|Clinical Infectious Diseases|2020Cited by 171
Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day MortalitySusan Olender, Marta Boffito, Theresa L. Walunas et al.|Open Forum Infectious Diseases|2021Cited by 45